Thales S.A. (LON:0IW5)

Revance Therapeutics Revenue

Thales had revenue of 10.26B EUR in the half year ending June 30, 2025, with 17.77% growth. This brings the company's revenue in the last twelve months to 21.35B, up 11.16% year-over-year. In the year 2024, Thales had annual revenue of 20.58B with 11.66% growth.

• Revenue (ttm): 21.35B EUR
• Revenue Growth: +11.16%
• P/S Ratio: 2.30
• Revenue / Employee: 257.15K EUR
• Employees: 83,020
• Market Cap: 42.16B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	20.58B	2.15B	11.66%
Dec 31, 2023	18.43B	859.60M	4.89%
Dec 31, 2022	17.57B	1.38B	8.50%
Dec 31, 2021	16.19B	821.00M	5.34%
Dec 31, 2020	15.37B	-3.03B	-16.47%